HealthInvestor Awards Winners 2014
 
 
Remember me:
Skip Navigation Links
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

27/08/2014
Specialist care provider Cambian Group has seen like-for-like growth in revenue and ebitda for the first half of the year.
26/08/2014
Sovereign Capital is to merge its supported living businesses, Eden Futures and Select Living Options.
22/08/2014
Outsourcing company Serco has announced plans to pull out of the clinical health services market in the UK.
21/08/2014
Primary Health Properties’ portfolio value, including development properties, has reached £1 billion in the first half of 2014.
20/08/2014
The Centre for Health & the Public Interest has said that private hospital operators should have the same inspection regime as NHS providers and provide more data on patient safety.


Candesic’s Dr David Royse and Dr Michelle Tempest investigate how patient empowerment, facilitated by the internet, is changing healthcare
Read more...
HealthInvestor Power Fifty 2014
The Care Act 2014 champions personalisation and preventative care, but fails to address burgeoning financial pressures on the care sector, finds Sunniva Davies-Rommetveit
Read more...
HealthInvestor tracks down the founder of Findmehealth.com to hear what the private healthcare comparison website is all about
The Corrigan-Parish ‘Going with change’ paper argues that brand new business models could facilitate much-needed NHS change
Medical facility construction is once again on the up in Dubai, but is it justified?
Eden Futures is paving the way for future social care, finds Sunniva Davies-Rommetveit
Ploy Radford catches up with Cygnet Health Care’s new chief executive, David Cole, to discover his plans for the mental health specialist

Click here to search all feature articles